Please login to the form below

Not currently logged in
Email:
Password:

BIIB059

This page shows the latest BIIB059 news and features for those working in and with pharma, biotech and healthcare.

Biogen doses first patient with litifilimab in cutaneous lupus erythematosus study

Biogen doses first patient with litifilimab in cutaneous lupus erythematosus study

Biogen has dosed the first patient in a global phase 2/3 study of litifilimab (also known as BIIB059) in participants with cutaneous lupus erythematosus (CLE), the company announced.

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Mednet Group

PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....